Raanan Berger

14.6k citations
159 papers · 7.3k · 5 hit papers · h-index 34

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Head and Neck Cancer Studies

Papers in

    • Prostate Cancer Treatment and Research 25
    • Renal cell carcinoma treatment 22
    • Cancer Immunotherapy and Biomarkers 36
    • Colorectal Cancer Treatments and Studies 10
    • Cancer Diagnosis and Treatment 8

Raanan Berger

153 papers receiving 7.2k citations

Raanan Berger's Hit Papers

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study 2017 · 261 citations
2610+7+14Years since publication4008001.2k

Peers

Raanan Berger
Comparison fields: 5 of 125
  • Oncology 3.5k
  • Otorhinolaryngology 397
  • Immunology 1.4k
  • Cancer Research 951
  • Pulmonary and Respiratory Medicine 1.5k
Replace Jean‐Pierre Delord with:
Jean‐Pierre Delord France
Genichiro Ishii Japan
Lauren A. Byers United States
Joseph I. Clark United States
Alessandro Lugli Switzerland
Luigi Tornillo Switzerland
Muh‐Hwa Yang Taiwan
Luis E. Raez United States
Yoon Kyung Jeon South Korea
Shunji Takahashi Japan
Raanan Berger relative to Jean‐Pierre Delord France Jean‐Pierre Delord's profile →
Citations per field
00.5×1.5×2.1×
Jean‐Pierre Delord · 1×
Citations per year

Countries citing papers authored by Raanan Berger

Since Specialization
Citations

This map shows the geographic impact of Raanan Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raanan Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raanan Berger more than expected).

Fields of papers citing papers by Raanan Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raanan Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raanan Berger. The network helps show where Raanan Berger may publish in the future.

Co-authors

The 25 scholars most cited alongside Raanan Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raanan Berger Line = papers co-authored together Raanan Berger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Hit paper breakdown →
20161302
2
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Hit paper breakdown →
20161135
3
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
Hit paper breakdown →
2004781
4
Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
Hit paper breakdown →
2008538
5
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Hit paper breakdown →
2017261
6 2003226
7 2001160
8 2004140
9 2008133
10 2014113
11 1996111
12 201592
13 201190
14 201590
15 201587
16 201986
17 200677
18 201574
19 201474
20 200664

About Raanan Berger

Raanan Berger is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 159 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (36 papers), Prostate Cancer Treatment and Research (25 papers), Renal cell carcinoma treatment (22 papers), Cancer Genomics and Diagnostics (21 papers), Bladder and Urothelial Cancer Treatments (17 papers), Colorectal Cancer Treatments and Studies (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (3.5k citations), Otorhinolaryngology (397 citations), Immunology (1.4k citations), Cancer Research (951 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Raanan Berger has collaborated with scholars based in Israel, United States and South Korea. Frequent co-authors include Laura Q.M. Chow, Jonathan D. Cheng, Shilpa Gupta, Jared Lunceford, Kumudu Pathiraja, Karl Heath, Joseph P. Eder, Christine K. Gause, Tanguy Y. Seiwert and Barbara Burtness. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact